Global Natural Killer Cells Therapeutics Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 NK Cell Therapies
  • 1.4.3 NK Cell Directed Antibodies
• 1.5 Market by Application
  • 1.5.1 Global Natural Killer Cells Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Cancer
  • 1.5.3 Gastrointestinal Diseases
  • 1.5.4 Immunoproliferative Disorders
  • 1.5.5 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Natural Killer Cells Therapeutics Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Natural Killer Cells Therapeutics Industry
    • 1.6.1.1 Natural Killer Cells Therapeutics Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Natural Killer Cells Therapeutics Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Natural Killer Cells Therapeutics Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Natural Killer Cells Therapeutics Market Perspective (2015-2026)
• 2.2 Natural Killer Cells Therapeutics Growth Trends by Regions
  • 2.2.1 Natural Killer Cells Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Natural Killer Cells Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Natural Killer Cells Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Natural Killer Cells Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Natural Killer Cells Therapeutics Players by Market Size
  • 3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Natural Killer Cells Therapeutics Market Concentration Ratio
  • 3.2.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2019
• 3.3 Natural Killer Cells Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Natural Killer Cells Therapeutics Product Solution and Service
• 3.5 Date of Enter into Natural Killer Cells Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2021-2026)

5 Natural Killer Cells Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Natural Killer Cells Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Natural Killer Cells Therapeutics Market Size (2015-2020)
• 6.2 Natural Killer Cells Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Natural Killer Cells Therapeutics Market Size (2015-2020)
• 7.2 Natural Killer Cells Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Natural Killer Cells Therapeutics Market Size (2015-2020)
• 8.2 Natural Killer Cells Therapeutics Key Players in China (2019-2020)
• 8.3 China Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
• 8.4 China Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Natural Killer Cells Therapeutics Market Size (2015-2020)
• 9.2 Natural Killer Cells Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Natural Killer Cells Therapeutics Market Size (2015-2020)
• 10.2 Natural Killer Cells Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Natural Killer Cells Therapeutics Market Size (2015-2020)
• 11.2 Natural Killer Cells Therapeutics Key Players in India (2019-2020)
• 11.3 India Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
• 11.4 India Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Natural Killer Cells Therapeutics Market Size (2015-2020)
• 12.2 Natural Killer Cells Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Natural Killer Cells Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Natural Killer Cells Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Affimed
  • 13.1.1 Affimed Company Details
  • 13.1.2 Affimed Business Overview and Its Total Revenue
  • 13.1.3 Affimed Natural Killer Cells Therapeutics Introduction
  • 13.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2015-2020))
  • 13.1.5 Affimed Recent Development
• 13.2 Celgene
  • 13.2.1 Celgene Company Details
  • 13.2.2 Celgene Business Overview and Its Total Revenue
  • 13.2.3 Celgene Natural Killer Cells Therapeutics Introduction
  • 13.2.4 Celgene Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.2.5 Celgene Recent Development
• 13.3 Fate Therapeutics
  • 13.3.1 Fate Therapeutics Company Details
  • 13.3.2 Fate Therapeutics Business Overview and Its Total Revenue
  • 13.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
  • 13.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.3.5 Fate Therapeutics Recent Development
• 13.4 Fortress Biotech
  • 13.4.1 Fortress Biotech Company Details
  • 13.4.2 Fortress Biotech Business Overview and Its Total Revenue
  • 13.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
  • 13.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.4.5 Fortress Biotech Recent Development
• 13.5 Glycostem Therapeutics
  • 13.5.1 Glycostem Therapeutics Company Details
  • 13.5.2 Glycostem Therapeutics Business Overview and Its Total Revenue
  • 13.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
  • 13.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.5.5 Glycostem Therapeutics Recent Development
• 13.6 Innate Pharma
  • 13.6.1 Innate Pharma Company Details
  • 13.6.2 Innate Pharma Business Overview and Its Total Revenue
  • 13.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
  • 13.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.6.5 Innate Pharma Recent Development
• 13.7 Nantkwest
  • 13.7.1 Nantkwest Company Details
  • 13.7.2 Nantkwest Business Overview and Its Total Revenue
  • 13.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
  • 13.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.7.5 Nantkwest Recent Development
• 13.8 Nkarta Therapeutics
  • 13.8.1 Nkarta Therapeutics Company Details
  • 13.8.2 Nkarta Therapeutics Business Overview and Its Total Revenue
  • 13.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
  • 13.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.8.5 Nkarta Therapeutics Recent Development
• 13.9 NKT Therapeutics
  • 13.9.1 NKT Therapeutics Company Details
  • 13.9.2 NKT Therapeutics Business Overview and Its Total Revenue
  • 13.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
  • 13.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.9.5 NKT Therapeutics Recent Development
• 13.10 Ziopharm Oncology
  • 13.10.1 Ziopharm Oncology Company Details
  • 13.10.2 Ziopharm Oncology Business Overview and Its Total Revenue
  • 13.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
  • 13.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2015-2020)
  • 13.10.5 Ziopharm Oncology Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer